Faeth Therapeutics, Inc.
FTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001829802
In the last 90 days, Faeth Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $333.8M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Faeth Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- +20 vs. Q4 2025
- Shares held
- 2.16M
- +2.11M (+4,369.6%) vs. Q4 2025
- Total value
- $68.0M
- +$67.5M (+13,104.0%) vs. Q4 2025
- New holders
- 22
- 3 more added
- Sold out
- 2
- 1 more reduced
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $333.8M |
| Q1 2026 | 30 | $68.0M |
| Q4 2025 | 10 | $514.8K |
| Q3 2025 | 9 | $466.2K |
| Q2 2025 | 10 | $600.0K |
| Q1 2025 | 20 | $760.2K |
| Q4 2024 | 24 | $1.16M |
| Q3 2024 | 19 | $1.32M |
| Q2 2024 | 24 | $1.31M |
| Q1 2024 | 25 | $2.43M |
| Q4 2023 | 24 | $2.05M |
| Q3 2023 | 23 | $2.38M |
| Q2 2023 | 26 | $3.58M |
| Q1 2023 | 27 | $4.71M |
| Q4 2022 | 28 | $3.93M |
| Q3 2022 | 31 | $4.47M |
| Q2 2022 | 40 | $7.06M |
| Q1 2022 | 43 | $8.21M |
| Q4 2021 | 38 | $19.7M |
| Q3 2021 | 42 | $37.1M |
| Q2 2021 | 34 | $22.7M |
| Q1 2021 | 40 | $45.8M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Faeth Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SBI Securities Co., Ltd. | 4 | $126 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 9 | $284 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 32 | $804 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,496 | $47.2K | 0.00% | +1,496 | New |
| UBS Group AG | 4,529 | $142.8K | 0.00% | +4,529 | New |
| Vanguard Fiduciary Trust Co | 6,307 | $198.8K | 0.00% | +6,307 | New |
| Ikarian Capital, LLC | 6,351 | $200.2K | 0.03% | −15,000−70.3% | Reduced |
| Vanguard Capital Management LLC | 7,750 | $244.3K | 0.00% | +7,750 | New |
| Morgan Stanley | 8,795 | $277.2K | 0.00% | +8,785+87,850.0% | Added |
| Jane Street Group, LLC | 8,872 | $279.6K | 0.00% | +8,872 | New |
| Geode Capital Management, LLC | 9,501 | $299.5K | 0.00% | +9,501 | New |
| Catalio Capital Management, LP | 14,718 | $463.9K | 0.10% | 00.0% | Unchanged |
| Balyasny Asset Management LLC | 16,205 | $510.8K | 0.00% | +16,205 | New |
| Fred Alger Management, LLC | 18,337 | $578.0K | 0.00% | +18,337 | New |
| Brevan Howard Capital Management LP | 20,333 | $640.9K | 0.01% | +20,333 | New |
| Boothbay Fund Management, LLC | 26,124 | $823.4K | 0.02% | +26,124 | New |
| Logos Global Management LP | 30,000 | $945.6K | 0.05% | +30,000 | New |
| Renaissance Technologies LLC | 32,041 | $1.01M | 0.00% | +20,525+178.2% | Added |
| Bank of America Corp | 33,025 | $1.04M | 0.00% | +32,719+10,692.5% | Added |
| Suvretta Capital Management, LLC | 34,549 | $1.09M | 0.03% | +34,549 | New |
| HRT Financial LP | 58,001 | $1.83M | 0.00% | +58,001 | New |
| Goldman Sachs Group Inc | 61,568 | $1.94M | 0.00% | +61,568 | New |
| Marshall Wace, LLP | 65,730 | $2.07M | 0.00% | +65,730 | New |
| Trails Edge Capital Partners, LP | 125,000 | $3.94M | 0.93% | +125,000 | New |
| Caligan Partners LP | 126,002 | $3.97M | 0.28% | +126,002 | New |
| StemPoint Capital LP | 132,873 | $4.19M | 0.81% | +132,873 | New |
| Franklin Resources Inc | 133,506 | $4.21M | 0.00% | +133,506 | New |
| Millennium Management LLC | 146,565 | $4.62M | 0.00% | +146,565 | New |
| Cormorant Asset Management, LP | 306,222 | $9.65M | 0.49% | +306,222 | New |
| Vivo Capital, LLC | 722,020 | $22.8M | 1.89% | +722,020 | New |
| Citigroup Inc | 0 | $0 | 0.00% | −294−100.0% | Sold out |
| BNP Paribas | 0 | $0 | 0.00% | −7−100.0% | Sold out |